AlphAIAlphAI — Financial news for AI agents
SEC EDGAROCT 51 min read$AIP

Bayview Legacy, LLC sold $2.4M of AIP (indirect holdings)

Bayview Legacy, LLC sold 100,000 indirectly-held shares of Arteris, Inc. (AIP) at $23.82 ($2.38M total) on 2026-10-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bayview Legacy, LLC
Published Oct 5, 2026, 8:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$AIP
Bearish
medium confidence
Mentioned
$AIP
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPBearishLow
01

Why it matters

The disclosed sale may modestly depress AIP's share price in the short term.

02

Market read

First‑report insider sale provides new data for traders monitoring AIP's ownership structure.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 5/10Novelty 5/10Timing: post‑market filing on Oct 5

Background

SEC Form 4 filing discloses insider transactions; Bayview Legacy, LLC is a 10% owner of Arteris.

Company-level read

Ticker impact

$AIPBearishMedium confidence
Context

Form 4 shows Bayview Legacy, LLC sold 100,000 shares of Arteris at $23.82, reducing its stake.

Expected impact

likely pressure as the market prices in the insider sell

Evidence & confidence

10% owner sold $2.38M of stock; such sales often weigh on price, though size is modest.

Counterpoint

What could challenge this read

The sale could be a routine liquidity move, not a bearish signal.

Key entities

  • company
    Arteris, Inc.

    Semiconductor IP provider listed on Nasdaq under ticker AIP.

  • insider
    Bayview Legacy, LLC

    10% owner of Arteris executing a pre‑arranged 10b5‑1 sale.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AIP insider trading history →

Related articles

AUG 13
$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

fool.com6 min
AUG 7
MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

scanx.trade3 min
AUG 6
$AIPHighAI 9/10

Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to

SEC EDGAR 8-K6 min